Bhubaneswar-based Biotech Startup Exsure raised ₹3 Cr in a seed round led by Unicorn India Ventures to reduce the toxicity of chemotherapy drugs.
Amount Raised
₹30 Million
Round Type
Seed
Investors
Description
Exsure, a startup focused on minimizing the toxicity of chemotherapy drugs, recently raised ₹3 Cr in a seed round led by Unicorn India Ventures. The company aims to empower cancer patients by providing targeted treatments and has started collaborating with distributors for global market expansion.
Who else raised in Medical and Biotechnology around the same time
Companies in the same sectors as Exsure that raised within 45 days of this round, from Fundz verified event records.
- Reveleum raised an undisclosed amount on March 6, 2025.
- Streamex Corp. raised $819K (Seed) on March 5, 2025.
- Cercare Medical raised $7.9M (Funding Round) on March 5, 2025.
- Nervonik raised $13M (Series A) on March 4, 2025.
- Arva Health raised $1M (Pre-Seed) on March 3, 2025.
- OCL Vision raised an undisclosed amount (Funding Round) on March 3, 2025.
Who to call at Exsure, and when
A new round usually means Exsure is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Exsure raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Exsure, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Exsure. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Exsure raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Exsure raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.